These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pharmacological evaluation of five novel dexamethasone heneicosoic (21) acid derivatives.
    Author: Hong SU, Park KH, Chae JS, Lee JW, Kim CS, Kim JK.
    Journal: Drugs Exp Clin Res; 1989; 15(11-12):511-20. PubMed ID: 2637793.
    Abstract:
    Five novel dexamethasone 21-oic acid derivatives (DM-I, II, IV, V and VI) were prepared from dexamethasone in accordance with the antedrug concept and their local anti-inflammatory activities and systemic untoward effects were evaluated through steroid receptor binding study, cotton pellet granuloma bioassay and acute pharmacological studies. The acetonide derivatives, DM-V and DM-VI, were found to possess much stronger affinities to glucocorticoid receptors than the acid ester derivatives, DM-I and DM-II, in vitro. In in vivo experiments, locally applied DM-V and DM-VI exerted potent inhibitory activity against granuloma formation; DM-I and DM-II also produced moderate granuloma inhibitory activity in spite of their weak affinity to the receptors. DM-II, DM-V and DM-VI manifested less systemic effects than dexamethasone, prednisolone and DM-I, such as thymus involution, suppression of plasma corticosterone and gluconeogenesis in the liver. Among the five compounds, DM-V could be exemplified as a potentially useful antedrug for topical or local application, since it has anti-inflammatory potency approaching that of the more traditional steroid prednisolone, but it does not have the systemic adverse effects.
    [Abstract] [Full Text] [Related] [New Search]